Download PDF
Ernährung & Medizin 2019; 34(02): 74-81
DOI: 10.1055/a-0831-6231
Wissen
© Georg Thieme Verlag KG Stuttgart · New York

Fasten für Menschen mit Typ-1-Diabetes (FaMeD1)

Pilotstudie in Hinblick auf Machbarkeit und diabetesbezogene Lebensqualität
Bettina Berger
,
Rainer Stange
,
Andrea Baumann
,
Diana Köblös
,
Daniela Liebscher
,
Martina Bley
,
Andreas Michalsen
,
David Martin
Further Information

Publication History

Publication Date:
17 June 2019 (online)

    Permissions and Reprints

Zusammenfassung

Typ-1-Diabetes mellitus (T1DM) ist eine fortschreitende und herausfordernde chronische Erkrankung, welche immer wieder neue emotionale Anpassungsleistungen erfordert [1]. Im folgenden Studienprotokoll wird das geplante Vorgehen zur Überprüfung der Machbarkeit und Sicherheit einer Buchinger-Fastenintervention bei Menschen mit Typ-1-Diabetes mellitus in Hinblick auf diabetesbezogene Problembereiche und unerwünschte Ereignisse wie Ketoazidosen und schwere Unterzuckerungen vorgestellt.

 

  • Literatur

  • 1 Berger B. Krankheit als Konstruktion – Diabetes mellitus im Vergleich von Schulmedizin und Homöopathie. Essen: KVC Verlag; Karl und Veronica Carstens-Stiftung; 2003
    CrossrefGoogle Scholar
  • 2 Goffrier B, Schulz M, Bätzing-Feigenbaum J. Administrative Prävalenzen und Inzidenzen des Diabetes mellitus von 2009 bis 2015. Versorgungsatlas.de. doi:10.20364/VA-17.03, Letzter Zugriff: 30.09.2017
    PubMedGoogle Scholar
  • 3 Menting J, Nikolaus S, van der Veld WM. et al. Severe fatigue in type 1 diabetes: Exploring its course, predictors and relationship with HbA(1c) in a prospective study. Diabetes Res Clin Pract 2016; 121: 127-134 doi:10.1016/j.diabres.2016.09.011
    CrossrefPubMedGoogle Scholar
  • 4 Wilhelmi de Toledo F, Buchinger A, Burggrabe H. et al. Medical Association for Fasting and Nutrition. Fasting therapy – an expert panel update of the 2002 consensus guidelines. Forsch Komplementmed 2013; 20: 434-443
    CrossrefPubMedGoogle Scholar
  • 5 Hauner H, Toeller M. Ist Fasten für Diabetiker gefährlich? Deutsches Diabetes-Forschungsinstitut Düsseldorf. 2001 Im Internet: http://www.diabetes-deutschland.de Letzter Zugriff: 12.01.2019
    PubMedGoogle Scholar
  • 6 Alabbood MH, Ho KW, Simons MR. The effect of Ramadan fasting on glycaemic control in insulin dependent diabetic patients: A literature review. Diabetes Metab Syndr 2017; 11: 83-87
    CrossrefPubMedGoogle Scholar
  • 7 Michalsen A, Li C. Fasting therapy for treating and preventing disease – current state of evidence. Forsch Komplementmed 2013; 20: 444-453
    CrossrefPubMedGoogle Scholar
  • 8 Michalsen A, Li C, Kaiser K. et al. In-Patient treatment of fibromyalgia: a controlled nonrandomized comparison of conventional medicine versus integrative medicine including fasting therapy. Evid Based Complement Alternat Med 2013; 2013: 908610
    PubMedGoogle Scholar
  • 9 Stange R, Pflugbeil C, Michalsen A. et al. Therapeutic fasting in patients with metabolic syndrome and impaired insulin resistance. Forsch Komplementmed 2013; 20: 421-426
    CrossrefPubMedGoogle Scholar
  • 10 Li C, Ostermann T, Hardt M. et al. Metabolic and psychological response to 7-day fasting in obese patients with and without metabolic syndrome. Forsch Komplementmed 2013; 20: 413-420
    CrossrefPubMedGoogle Scholar
  • 11 Berger B, Stange R, Michalsen A. et al. Prolonged fasting in T1DM – case study from patient perspective. Berlin: European Conference of Integrative Medicine; 2017
    Google Scholar
  • 12 Merger SR, Kerner W, Stadler M. et al. Prevalence and comorbidities of double diabetes. Diabetes Res Clin Pract 2016; 119: 48-56
    CrossrefPubMedGoogle Scholar
  • 13 Fond G, Macgregor A, Leboyer M. et al. Fasting in mood disorders: neurobiology and effectiveness. A review of the literature. Psychiatry Res 2013; 209: 253-258
    CrossrefPubMedGoogle Scholar
  • 14 Choi IY, Piccio L, Childress P. et al. A diet mimicking fasting promotes regeneration and reduces autoimmunity and multiple sclerosis symptoms. Cell Rep 2016; 15: 2136-2146
    CrossrefPubMedGoogle Scholar
  • 15 Misra S, Oliver NS. Utility of ketone measurement in the prevention, diagnosis and management of diabetic ketoacidosis. Diabetic Medicine 2015; 32: 14-23
    PubMedGoogle Scholar
  • 16 Balasse EO, Féry F. Ketone body production and disposal: Effects of fasting, diabetes, and exercise. Diabetes/Metabolism Reviews 1989; 5: 247-270
    CrossrefPubMedGoogle Scholar
  • 17 Hall SE, Wastney ME, Bolton TM. et al. Ketone body kinetics in humans: the effects of insulin-dependent diabetes, obesity, and starvation. J Lipid Res 1984; 25: 1184-1194
    CrossrefPubMedGoogle Scholar
  • 18 Remer T, Berkemeyer S, Rylander R. et al. Muscularity and adiposity in addition to net acid excretion as predictors of 24-h urinary pH in young adults and elderly. Eur J Clin Nutr 2007; 61: 605-609
    CrossrefPubMedGoogle Scholar
  • 19 Remer T, Dimitriou T, Manz F. Dietary potential renal acid load and renal net acid excretion in healthy, free-living children and adolescents. Am J Clin Nutr 2003; 77: 1255-1260
    CrossrefPubMedGoogle Scholar
  • 20 Storch M. Resource-activating selfmanagement with the Zurich Resource Model (ZRM). European Psychotherapy 2004; 5: 27-64
    PubMedGoogle Scholar